DCGI approves market authorisation for SII’s Covid vaccine Covovax as heterologous booster dose
New Delhi: The Drug Controller General of India (DCGI) has approved market authorisation to COVID-19 vaccine Covovax as a heterologous ...
Read more
New Delhi: The Drug Controller General of India (DCGI) has approved market authorisation to COVID-19 vaccine Covovax as a heterologous ...
Read moreNew Delhi: A day after its Covid shot ‘Covovax’ was included on the CoWIN portal for inoculation of children aged ...
Read moreNew Delhi: The COVID-19 Working Group of the NTAGI has recommended inclusion of the Serum Institute's Covovax in the national ...
Read moreNew Delhi: The Drugs Controller General of India (DCGI) granted permission on Wednesday for conducting the phase-3 clinical trial of ...
Read moreNew Delhi: Serum Institute of India (SII) has urged the Union government to include Covovax in the National Covid-19 vaccination ...
Read moreNew Delhi: Serum Institute of India (SII) has sought emergency use authorisation (EUA) from DGCI for its Covid-19 vaccine ‘Covovax’ ...
Read moreNew Delhi: Expanding India’s vaccine basket, the Central Drug Authority has approved the Serum Institute of India’s Covid-19 vaccine ‘Covovax’, ...
Read moreNew Delhi: Serum Institute of India (SII) plans to launch a Covid-19 vaccine for children in the next six months. ...
Read moreNew Delhi: Serum Institute of India (SII) CEO Adar Poonawalla Saturday said clinical trials of COVID-19 vaccine Covovax have begun in ...
Read more
I t may appear strange in most democracies, including India, that losing a no-confidence vote against a government leading to...
Read more
The collapse of Bashar al-Assad’s regime in Syria is not an isolated event in the Middle East, but part of...
Read more
The people of South Korea and their representatives showed the world last weekend how real democracy works. The country’s parliament...
Read more
In 2021, I wrote a book called “Price of the Modi Years.” In one of its chapters, I compared India’s...
Read more
